Amyotrophic lateral sclerosis (ALS) is a late onset neurodegenerative disorder characterized by the loss of motor neurons. FUS/TLS and TDP-43 are DNA/RNA binding proteins found to be mutated in sporadic and familial forms of amyotrophic lateral sclerosis (ALS). Ectopic expression of human ALS-causing FUS/TLS mutations in Drosophila caused an accumulation of ubiquitinated proteins, neurodegeneration, larval crawling defect and early lethality. Mutant FUS/TLS localized to both the cytoplasm and nucleus, whereas wild type FUS/TLS localized only to the nucleus, suggesting that the cytoplasmic localization of FUS/TLS is required for toxicity. Furthermore, we found that deletion of the nuclear export signal strongly suppressed toxicity, suggesting that cytoplasmic localization is necessary for neurodegeneration.
Here, we describe a Drosophila model of FUS/TLS-mediated ALS that recapitulates several key features of human ALS pathology. Targeted expression of mutant human FUS/TLS in Drosophila eyes and motor neurons led to eye degeneration and locomotor dysfunction, respectively. Wild type FUS predominantly localized in the nucleus whereas mutant FUS/TLS was distributed in both the cytoplasm and nucleus suggesting that cytoplasmic localization is required for causing toxicity. Interestingly, deletion of the nuclear export signal (ΔNES) rescued toxicity associated with mutant FUS/TLS, suggesting that cytoplasmic localization of mutant 
Results

Ectopic expression of mutant FUS/TLS leads to neurodegeneration in Drosophila
In order to investigate the molecular mechanisms of FUS/TLS related neurodegeneration, we generated transgenic flies over expressing HA-tagged wild type or mutant human FUS using the highly versatile UAS/GAL4 system (Brand and Perrimon, 1993) . We found that targeted expression of mutant human FUS/TLS (R518K, R521C and R521H) caused severe neurodegeneration in Drosophila eyes characterized by disorganized ommatidia and loss of mechanosensory bristles ( Figure 1A , 1B and 1C), whereas expression of wild-type human FUS/TLS resulted in very mild eye degeneration ( Figure 1 ). We did quantitation of the eye phenotype in the flies expressing wild type and mutant FUS/TLS (1C) using our previously published criteria (Pandey et al., 2007) . The eyes appear degenerated externally in flies ectopically expressing FUS/TLS containing ALS-associated R518K, R521C, and R521H mutations, and this correlates with vacuolar neurodegeneration with severe disruption of the retinal organization and thinning of the retina ( Figure 1B ). We used two independent insertion lines for validation of the mutation dependent phenotype (Supplementary Figure 1A) . In order to understand the consequences of mutant FUS/TLS in the nervous system, we targeted FUS/TLS expression to neurons using a pan-neuronal driver (appl-gal4) and found that mutant FUS/TLS (R518K, R521H and R521C) caused pupal lethality, whereas the WT FUS/TLS expressing flies eclosed normally (1D). These findings further confirm that the neurons are highly vulnerable to expression of mutant FUS/TLS. Interestingly, ectopic expression of mutant FUS using the Applgal4 (pan-neuronal expression) and OK371-gal4 (motor neurons expression) caused pupal lethality. We observed a mutation-dependent degenerative phenotype despite almost equal FUS/TLS protein expression levels ( Figure 1E and Supplementary Figure 1B) . Interestingly, we observed a mutation dependent accumulation of ubiquitin positive proteins in FUS expressing animals (Supplementary Figure 2) . Taken together, these results demonstrate that expression of human ALS-related FUS/TLS mutations cause mutation-dependent neurodegenerative phenotypes, consistent with a gain-of-toxicity mechanism that has been proposed for this disease.
Conditional expression of mutant FUS/TLS in adult flies causes a severe locomotor defect and increases mortality
Because targeted expression of mutant FUS/TLS in the fly nervous system during development caused pupal lethality, we decided to use the conditional expression system elav-GeneSwitch Approximately 50% of the FUS R521C flies were dead within 18 days of RU486 treatment with all of the flies dead in 30 days (average life span 17.4 days). Flies expressing FUS WT started dying after 10 days of RU486 treatment, but their rate of death was significantly slower as compared to the FUS R521C expressing animals (50% of FUS WT flies were dead in 28 days vs. 50% of FUS R521C flies were dead after 18 days) (Figure 2A and 2B). We found that the overall mutation-dependent reduction in life span was similar in males and females with all of the male flies dead in 29 days. Flies expressing the driver alone did not have a significant difference in life span after exposure to RU-486, as over 90% flies were viable after 30 days of RU486 exposure (Figure 2A and 2B) . These findings further demonstrate a mutation-dependent decline in the life span of the FUS R521C expressing animals. However, wild type FUS expressing animals also showed a decline in life span, but the degree of severity was less than mutant FUS animals. Because ALS is an age-related motor neuron disease, we sought to determine the effect of FUS/TLS expression on adult locomotor function using a well established adult climbing assay that has been extensively used to characterize Drosophila models of neurodegenerative diseases (Feany and Bender, 2000; Crowther et al., 2005) . We found that induction of FUS/TLS by RU486 from day 1 adult stage caused an age-dependent decline in climbing ability ( Figure   2C ), and this phenotype is more severe in flies expressing mutant FUS/TLS when compared with wild type. The FUS R521C flies induced with RU486 started showing impairment in the climbing behavior by day 10 and at day 20 less than 3% of the FUS R521C flies treated with RU486 were able to climb as compared to 41% of the FUS WT flies treated with RU486 ( Figure   2C ). As expected, there was no FUS protein expression in day 1 elav-GS; UAS-FUS WT and elav-GS; UAS-FUS R521C flies before exposure to the inducing agent RU486. However, we observed robust FUS/TLS protein expression in day 15 elav-GS; UAS-FUS WT and elav-GS; UAS-FUS R521C flies exposed to RU486 ( Figure 2D ). We observed a very mild leaky expression of FUS/TLS in day 15 flies even when not exposed to RU486 as reported previously (Wu et al., 2005) . Collectively, our data demonstrate that expression of mutant FUS/TLS specifically in the neurons of the adult fly leads to a severe decline in life span and a progressive adult locomotor defect. Hence, we developed a conditional Drosophila model of ALS that can potentially serve as a useful system for further investigating the potential mechanisms underlying pathogenesis in ALS, without any confounding effects on neuronal development.
Motor neuron expression of mutant FUS/TLS causes a larval crawling defect without apparent morphological defects at the neuromuscular junction (NMJ)
In order to investigate the mechanisms underlying locomotor dysfunction with mutant FUS expression, we targeted expression of FUS/TLS to motor neurons using the OK371-gal4 driver.
We performed a larval crawling assay to determine the locomotor function of 3 rd instar larvae expressing WT and mutant forms of FUS/TLS in motor neurons (Batlevi et al., 2010) . We found that expression of FUS R518K, FUS R521C and FUS R521H in motor neurons caused a larval crawling defect as compared to FUS WT and driver alone ( Figure 3A ). These observations prompted us to investigate if the larval crawling defect could be explained by morphological defects at the NMJ. In order to determine the morphology of synaptic boutons at the NMJ, we used the cysteine-string protein (CSP) and the discs large (DLG) protein as markers for presynaptic and post-synaptic compartments respectively and counted the number of synaptic boutons at the NMJ. The animals expressing FUS R521C and FUS R521H displayed normal numbers of synaptic boutons with no apparent differences with FUS WT and driver alone ( Figure 3B ). We also found that animals expressing FUS R521C and FUS R521H have a similar number of synaptic boutons as compared to FUS WT and driver alone ( Figure 3C ). This suggests that the ALS-linked FUS mutations do not disrupt formation of the NMJ.
Deletion of the nuclear export signal strongly suppresses toxicity associated with mutant Figure 4A and 4B). Interestingly, targeted expression of double mutants (FUS ΔNES R518K and FUS ΔNES R521C) also showed almost normal ommatidial architecture externally and internally as evident from light microscopy and histology ( Figure 4A and 4B ).
FUS/TLS
These data demonstrate that the deletion of the conserved NES strongly mitigates toxicity. We validated these findings using three independent transgenic lines as shown in Supplementary   Figure 3 .
Next, we determined if deletion of the NES could abrogate the pupal lethality associated with neuronal expression of mutant FUS/TLS ( Figure 1D ). We found that flies expressing the single mutation (FUS ΔNES) and the double mutations (FUS ΔNES R518K and FUS ΔNES R521C) in neurons eclosed normally, just as the FUS WT and driver alone do ( Figure 4C ). These findings suggest that deletion of NES can suppress mutation-dependent FUS/TLS toxicity in Drosophila eyes and neurons. We further determined the expression level of FUS/TLS protein in FUS ΔNES, FUS ΔNES R518K and FUS ΔNES R521C mutants and found that these animals express comparable FUS protein levels to the FUS WT, FUS R518K and FUS R521C ( Figure   4D ). These observations suggest that deletion of NES does not destabilize the expression level of FUS/TLS protein. Together, these findings suggest that the NES domain is required for mutation-dependent FUS/TLS toxicity in Drosophila eyes and neurons.
Wild type FUS/TLS is predominantly nuclear whereas mutant FUS/TLS is also distributed into the cytoplasm. Deletion of the nuclear export signal restricts FUS/TLS expression to the nucleus.
In order to determine the sub-cellular localization of FUS/TLS, we targeted the expression of FUS WT and FUS R518K transgenes to motor neurons using the driver OK371-GAL4. We used anti-lamin antibody to highlight the nuclear envelope, and thus staining inside the lamin ring is nuclear and outside the ring is cytoplasmic. We found that wild type and mutant FUS/TLS display a different sub-cellular localization in Drosophila third instar larvae motor neurons. Wild type FUS/TLS localized exclusively to the nucleus while FUS R518K was present in the cytoplasm as well as the nucleus ( Figure 5 ). Wild type FUS/TLS (B) can be clearly seen localized to the nucleus while mutant FUS R518K staining is also seen in the cytoplasm, outside of the lamin ring ( Figure 5C magnified image).
Because we observed a strong suppression of mutant FUS/TLS toxicity by deleting the nuclear export signal, we sought to determine the sub cellular distribution of FUS/TLS in the FUS ΔNES single and double mutant lines. We observed that when the nuclear export signal (NES) was deleted from FUS WT or FUS R518K, then both FUS ΔNES ( Figure 5D ) and the mutant FUS ΔNES R518K ( Figure 5E ) were predominantly retained inside the nucleus, suggesting that cytoplasmic localization of mutant FUS/TLS is important for causing ALS pathogenesis. We performed a quantification of cytoplasmic and nuclear localization in motor neurons that showed a significant localization of mutant FUS in the cytoplasm as compared to WT and ΔNES (single and double mutants (Supplementary Figure 4) .
Genetic interaction between human FUS/TLS and TDP-43
TDP - We found that targeted expression of FUS/TLS in motor neurons leads to a mutation-dependent larval crawling defect in 3 rd instar larvae. However, our examination of NMJ structure in a Drosophila model of FUS/TLS-related ALS using the respective pre-and post-synaptic markers, CSP and DLG, revealed normal number of synaptic boutons in both WT and mutant FUS/TLS expressing animals. This suggests that the decline in motor neuron function starts before synaptic retraction at the NMJ ( Figure 3 ). Future electrophysiological studies will be necessary to understand more thoroughly the functional consequences of mutant FUS/TLS expression in our Drosophila model of ALS.
Deletion of the nuclear export signal (NES) blocks toxicity associated with mutant FUS/TLS
FUS/TLS localizes in the nucleus, but due to ALS causing mutations, FUS/TLS is found in the nucleus and the cytoplasm in affected neurons. We found that WT FUS/TLS predominantly localizes in the nucleus whereas FUS/TLS with ALS causing mutations is found to be in both the cytoplasm as well as remaining in the nucleus ( 
Materials and Methods
Plasmid construction
To generate the pUAST-FUS constructs, human FUS cDNA was excised from pCI-Neo FUS WT, pCI-Neo-FUS R521C and pCI-Neo-FUS R521H vectors by XhoI-XbaI restriction enzyme digestion and sub-cloned into the XhoI-XbaI sites of the pUAST vector. All FUS constructs had an HA tag (YPYDVPDYA) coding sequence previously inserted at their 5' ends. FUS mutant R518K was generated with the QuikChange II Site-Directed Mutagenesis Kit (Stratagene). The template DNA was pUAST-FUS WT with the primers R518K-F and R518K-R shown in Table   S1 . The manufacturer's suggested protocol was followed. All mutations and deletions were verified by sequencing.
For the deletion of the NES domain of human FUS (amino acids VQGLGENVTI) the Phusion
Site-Directed Mutagenesis Kit was used with the primers ΔNES-F and ΔNES-R (Table 1) following the suggested protocol. The FUS ΔNES construct was excised from the pCIneo vector and inserted into the same location in pUAST.
The double mutants pUAST-FUS ΔNES R518K and pUAST-FUS ΔNES R521C were derived from pCIneo ΔNES in the following manner. The enzyme EcoRI cuts out a fragment that spans the entire RRM domain which includes the NES domain. The NES deleted regions from pCIneo ΔNES were cut in this manner and then inserted into both pUAST-FUS R518K and pUAST R521C vectors from which the EcoRI fragment had been removed. The correct insertion and orientation of the subcloned region containing the ΔNES mutation was verified by sequencing.
Fly culture
All Drosophila stocks were maintained on standard Bloomington medium at 25°C in light/dark-
controlled incubators. Flies transgenic for UAS-FUSWT, UAS-FUS R518K, UAS-FUS R521H,
UAS-FUS R521C, FUS ΔNES, FUS ΔNES R518K and FUS ΔNES R521C were generated by injecting the constructs described above into w1118 embryos using standard techniques at the Best Gene Inc. The UAS-TDP-43 WT and UAS-TDP-43 M337V lines were described previously (Ritson et al., 2010) .
Light microscopy of fly eyes
Eye phenotypes of 1-day-old CO 2 -anesthetized flies were evaluated with a Leica M 205C stereomicroscope and photographed with a Leica DFC420 digital camera. For each genotype and condition 100 to >1000 flies were evaluated and quantitation of eye phenotypes was done as described previously (Pandey et al., 2007) .
Scanning Electron Microscopy (SEM)
Samples for SEM were collected and fixed in 2.5% gluteraldehyde (Ted Pella, Inc.) in PBS and post-fixed for 15-30 minutes in 1.5% osmium tetroxide (Ted Pella, Inc.) in PBS. Samples were dehydrated in ethanol, washed in hexamethyldisilazane (Ted Pella, Inc.) and dried in a dessicator for three days. Specimens were coated with gold:palladium using a Denton DV-503 vacuum evaporator, and analyzed using an AMRAY 1820D scanning electron microscope.
Histology
For histology of fly eyes, heads of the appropriate genotype were collected and fixed in 4% buffered paraformaldehyde in PBS for 2 h at room temperature. Samples were serially dehydrated in ethanol and processed as described previously (Pandey et al., 2007) .
Larval crawling assay and eclosion rate assay
Third instar wandering larvae of the indicated genotypes (>30 larvae/genotype) were washed in PBS and placed on a 1% agarose gel in a Petri dish with gridlines spaced at 5 mm. The larvae were allowed to acclimate for 1 min, and the number of grid lines that the posterior end of the larvae passed in 1 min was determined as described previously (Batlevi et al., 2010) . Eclosion rate of WT and mutant FUS expressing flies were determined as described previously (Ritson et al., 2010) .
Life span and adult climbing assays
Flies were crossed in the absence of RU486 on standard fly food. Day 1 adult males and females were separated and transferred on to experimental vials containing fly food mixed with or without RU486 (20 mM) at a density of 25 flies per vial (n >200). Deaths were scored every other day and flies were transferred to fresh food three times a week. Adult locomotor function was assessed by a previously described method (Feany and Bender, 2000; Crowther et al.,
2005).
Western blotting
Western blotting was performed as described previously (Pandey et al., 2007) . Briefly, three fly heads were used for protein extraction in RIPA buffer followed by sonication and separation on 
Immunohistochemistry and NMJ analysis
Wandering third instar larvae were dissected and fixed with 4% formaldehyde for 15-25 minutes. It also illustrates the significant difference between the resulting cross (**) with each of the genotypes (*) used for the respective cross (p<0.01 in all cases). 
Antibodies used included anti-FUS (Bethyl
